Abstract: Objective: By presenting a case study on multiple instances of Bowen's disease and the consistent use of narrow-band ultraviolet B (NB-UVB) phototherapy over a three-year period, our aim is to enhance the comprehension of domestic clinicians regarding the disease. Additionally, we seek to review existing literature, encouraging dermatologists to consider clinical secondary primary lesion diagnoses.
Method: Our approach involves analyzing a diagnosed case of multiple Bowen's disease, examining clinical manifestations, histopathology, imaging results, and treatment methods related to NB-UVB phototherapy. We aim to facilitate discussion and understanding through a comprehensive literature analysis.
Results: An elderly male with a 30-year history of psoriasis vulgaris initiated continuous NB-UVB therapy three years ago. A year later, he developed red patches and plaques with distinct borders and scaly surfaces on his face, trunk, lower extremities, and scrotum. Histopathological examination confirmed Bowen's disease. Treatment involved liquid nitrogen cryotherapy, with no recurrence observed during the one-year follow-up.
Conclusion: This case highlights that Bowen's disease, typically solitary, can manifest as multiple instances, especially in individuals with a history of psoriasis vulgaris. While NB-UVB stands as the primary treatment for psoriasis vulgaris, caution is warranted due to the potential risk of skin tumor induction with prolonged high-dose usage. Clinicians should be vigilant in monitoring and assessing the long-term implications of such therapies.
(© 2024 The Authors. Journal of Cosmetic Dermatology published by Wiley Periodicals LLC.)
References: Singh S, Khaitan BK, Sharma MC, Seenu V, Kumawat M, Chatterjee P. Bowen's disease on finger: a diagnostic and therapeutic challenge. Indian J Dermatol Venereol Leprol. 2013;79(2):227‐230. doi:10.4103/0378-6323.107643.
Kim YS, Park GS, Bang CH, Chung YJ. Genomic landscape of multiple Bowen's disease using whole‐exome sequencing. J Dermatol. 2022;50:397‐400. doi:10.1111/1346-8138.16584.
Švajdler M Jr, Mezencev R, Kašpírková J, et al. Human papillomavirus infection and p16 expression in the immunocompetent patients with extragenital/extraungual Bowen's disease. Diagn Pathol. 2016;11(1):53. doi:10.1186/s13000-016-0505-3.
Lo TK, Chen YC, Liu WT, Wong TW. Successful treatment of giant Bowen's disease with photodynamic therapy and subsequent imiquimod in a case with chronic arsenic exposure. Photodiagnosis Photodyn Ther. 2022;40:103128. doi:10.1016/j.pdpdt.2022.103128.
Gopalan K, Vellaisamy SG, Manickam N, Ahamed R. Anti‐retroviral therapy's miracle in the treatment of Bowen's disease in a human immunodeficiency virus‐positive patient: a rare case report. Indian J sex Transm dis Aids. 2016;37(2):201‐204. doi:10.4103/0253-7184.192123.
Iannacone MR, Sinnya S, Pandeya N, et al. Prevalence of skin cancer and related skin tumors in high‐risk kidney and liver transplant recipients in Queensland, Australia. J Invest Dermatol. 2016;136(7):1382‐1386. doi:10.1016/j.jid.2016.02.804.
Wozniak‐Rito AM, Rudnicka L. Bowen's disease in Dermoscopy. Acta Dermatovenerol Croat. 2018;26(2):157‐161.
D'Orazio J, Jarrett S, Amaro‐Ortiz A, Scott T. UV radiation and the skin. Int J Mol Sci. 2013;14(6):12222‐12248. doi:10.3390/ijms140612222.
Qin JZ, Chaturvedi V, Denning MF, et al. Regulation of apoptosis by p53 in UV‐irradiated human epidermis, psoriatic plaques and senescent keratinocytes. Oncogene. 2002;21(19):2991‐3002. doi:10.1038/sj.onc.1205404.
Ouhtit A, Gorny A, Muller HK, Hill LL, Owen‐Schaub L, Ananthaswamy HN. Loss of Fas‐ligand expression in mouse keratinocytes during UV carcinogenesis. Am J Pathol. 2000;157(6):1975‐1981. doi:10.1016/S0002-9440(10)64836-5.
Ouhtit A, Muller HK, Davis DW, Ullrich SE, McConkey D, Ananthaswamy HN. Temporal events in skin injury and the early adaptive responses in ultraviolet‐irradiated mouse skin. Am J Pathol. 2000;156(1):201‐207. doi:10.1016/S0002-9440(10)64720-7.
Wrone‐Smith T, Bergstrom J, Quevedo ME, Reddy V, Gutierrez‐Steil C, Nickoloff BJ. Differential expression of cell survival and cell cycle regulatory proteins in cutaneous squamoproliferative lesions. J Dermatol Sci. 1999;19(1):53‐67. doi:10.1016/s0923-1811(98)00052-8.
Lee DY, Choi KH, Park SH, Lee JY, Yoon TY. Lobulated Bowen's disease with a clear cell change. Ann Dermatol. 2017;29(4):487‐490. doi:10.5021/ad.2017.29.4.487.
Mazzilli S, Gamo‐Villegas R, Pampin‐Franco A, et al. Reflectance confocal microscopy of pigmented Bowen's disease: a case series of difficult to diagnose lesions. Case Rep Dermatol. 2020;12(2):98‐106. doi:10.1159/000507916.
Verzì AE, Lacarrubba F, Caltabiano R, Broggi G, Musumeci ML, Micali G. Reflectance confocal microscopy features of plaque psoriasis overlap with horizontal histopathological sections: a case series. Am J Dermatopathol. 2019;41(5):355‐357. doi:10.1097/DAD.0000000000001297.
Rstom S, Abdalla B, Blumetti T, Matos L, Pinhal M, Paschoal F. Dermoscopy and reflectance confocal microscopy in actinic keratosis, intraepithelial carcinoma, and invasive squamous cell carcinoma. J Drugs Dermatol. 2022;21(3):259‐268. doi:10.36849/JDD.5086.
Ahlgrimm‐Siess V, Cao T, Oliviero M, et al. Seborrheic keratosis: reflectance confocal microscopy features and correlation with dermoscopy. J Am Acad Dermatol. 2013;69(1):120‐126. doi:10.1016/j.jaad.2012.12.969.
Palaniappan V, Karthikeyan K. Bowen's disease. Indian Dermatol Online J. 2022;13(2):177‐189. doi:10.4103/idoj.idoj_257_21.
Neubert T, Lehmann P. Bowen's disease – a review of newer treatment options. Ther Clin Risk Manag. 2008;4(5):1085‐1095.
Morton CA, Birnie AJ, Eedy DJ. British Association of Dermatologists' guidelines for the management of squamous cell carcinoma in situ (Bowen's disease) 2014. Br J Dermatol. 2014;170(2):245‐260. doi:10.1111/bjd.12766.
Xue WL, Ruan JQ, Liu HY, He HX. Efficacy of photodynamic therapy for the treatment of Bowen's disease: a meta‐analysis of randomized controlled trials. Dermatology. 2022;238(3):542‐550. doi:10.1159/000519319.
Processing Request
No Comments.